Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00201) | |||||
---|---|---|---|---|---|
Name |
Dimenhydrinate
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
DIMENHYDRINATE; Dramamine; 523-87-5; Chloranautine; Vomex A; Diphenhydrinate; Anautine; Travelin; Amosyt; Aviomarin; Gravol; Menhydrinate; Andramine; Antemin; Diamarin; Dimenest; Dimentabs; Dramalen; Dramamin; Dramarin; Dramilin; Eldodram; Gravinol; Hydrinate; Novamine; Permital; Supremal; Teodramin; Travelmin; Troversin; Xamamina; Dimate; Dramyl; Dromyl; Reise-Engletten; Neo-Navigan; Diphenhydramine Theoclate; Theohydramine; Diphenhydramine 8-chlorotheophylline; Diphenhydramine 8-chlorotheophyllinate; UNII-JB937PER5C; NSC 117855; JB937PER5C; C24H28ClN5O3; MFCD00054265; O-Benzhydryldimethylaminoethanol 8-chlorotheophyllinate; NSC-117855; (o-Benzhydryl(dimethylamino)ethanol) 8-chlorotheophyllinate; Benzhydryl-beta-dimethylaminoethylether 8-chlorotheophylline; N,N-Dimethyl-2-diphenylmethoxyethylamine 8-chlorotheophyllinate; 2-(Diphenylmethoxy)-N,N-dimethylethylamine 8-chlorotheophyllinate; beta-Dimethylaminoethyl benzhydryl ether 1,3-dimethyl-8-chloroxanthine; 2-(Benzhydryloxy)-N,N-dimethylethylamine compd. with 8-chlorotheophylline; Dimenhydrinat; Dommanate; Lomarin; Reidamine; Removine; Emedyl; Faston; Novamin (VAN); Gravinol (antiemetic); Dimenidrinato [DCIT]; SR-05000001608; [o-Benzhydryl(dimethylamino)ethanol] 8-chlorotheophyllinate; Dimenhydrinatum [INN-Latin]; Dimenidrinato; Dimenhidrinato [INN-Spanish]; CCRIS 4798; HSDB 3064; 2-benzhydryloxy-N,N-dimethylethanamine;8-chloro-1,3-dimethyl-7H-purine-2,6-dione; Dramamine (TN); NCI-C60639; Dimenhydrinate,(S); EINECS 208-350-8; Spectrum_000974; Prestwick3_000265; Spectrum2_000992; Spectrum3_000397; Spectrum4_000517; Spectrum5_000909; DSSTox_CID_5087; SCHEMBL5128; DSSTox_RID_77660; DSSTox_GSID_25087; BSPBio_000110; BSPBio_002213; KBioGR_001093; KBioSS_001454; DivK1c_000049; SPECTRUM1500251; SPBio_001083; BPBio1_000122; CHEMBL1200406; DTXSID9025087; CHEBI:94848; HMS500C11; KBio1_000049; KBio2_001454; KBio2_004022; KBio2_006590; KBio3_001433; Dimenhydrinate (JP17/USP/INN); NINDS_000049; HMS1920G20; HMS2091O08; HMS2095F12; HMS3712F12; Pharmakon1600-01500251; 2-(Benzhydryloxy)-N,N-dimethylethylamine 8-chlorotheophyllinate; HY-B1215; Dimenhydrinate [USP:INN:BAN:JAN]; Tox21_200323; CCG-40210; NSC117855; NSC756740; AKOS015896341; AC-8241; CS-4841; DB00985; NSC-756740; Ethylamine, N,N-dimethyl-2-(diphenylmethoxy)-, compd. with 8-chlorotheophylline; IDI1_000049; NCGC00021154-01; NCGC00021154-02; NCGC00021154-03; NCGC00021154-04; NCGC00021154-05; NCGC00021154-06; NCGC00021154-07; NCGC00091928-01; NCGC00091928-02; NCGC00091928-03; NCGC00257877-01; AS-13166; SBI-0051350.P003; AB00053833; FT-0625019; FT-0696921; D00520; J10430; WLN: T56 BM DN FNVNVJ CG F H &622; 523D875; Q420439; SR-05000001608-1; SR-05000001608-2; BRD-M98649031-001-01-1; Dimenhydrinate, European Pharmacopoeia (EP) Reference Standard; Dimenhydrinate, United States Pharmacopeia (USP) Reference Standard; Ethylamine 2-(diphenylmethoxy)-N, compd. with 8-chlorotheophylline (1:1); Theophylline, compd. with 2-(diphenylmethoxy)-N,N-dimethylethylamine (1:1); Dimenhydrinate, Pharmaceutical Secondary Standard; Certified Reference Material; Theophylline, compd. with 2-(diphenylmethoxy)-N,N-(dimethylethyl)amine (1:1)
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Functional nausea/vomiting | ICD-11: DD90 | [1] | ||
PubChem CID | |||||
Formula |
C24H28ClN5O3
|
||||
Canonical SMILES |
CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
|
||||
InChI |
1S/C17H21NO.C7H7ClN4O2/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16;1-11-4-3(9-6(8)10-4)5(13)12(2)7(11)14/h3-12,17H,13-14H2,1-2H3;1-2H3,(H,9,10)
|
||||
InChIKey |
NFLLKCVHYJRNRH-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=10660"></iframe>
|
||||
3D MOL is unavailable | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 470 | Topological Polar Surface Area | 81.8 | |
XlogP | N.A. | Complexity | 509 | ||
Heavy Atom Count | 33 | Rotatable Bond Count | 6 | ||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 5 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Dimenhydrinate 50 mg tablet | Click to Show/Hide the Full List of Formulation(s): 16 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Maltodextrin; Aspartame; Fd&c yellow no. 6; Magnesium stearate; Sorbitol; Aluminum oxide
|
|||||
Dosage Form | Chewable Tablet | |||||
Company | Medtech Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Aspartame | DIG Info | Pregnane X receptor (Ki = 13 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [6] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous citric acid; Maltodextrin; Aspartame; Fd&c yellow no. 6; Magnesium stearate; Sorbitol
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Navajo Manufacturing | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Aspartame | DIG Info | Pregnane X receptor (Ki = 13 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Dextrin | DIG Info | Colon cancer Caco-2 cells (Inhibition ratio > 55 %) | [6] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Anhydrous dibasic calcium phosphate; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | CVS Pharmacy; L&R Distributors | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Anhydrous dibasic calcium phosphate; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | L.N.K. International | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Anhydrous dibasic calcium phosphate; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Wal-Mart Stores | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Calcium hydrogenphosphate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Croscarmellose sodium; Silicon dioxide; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Qualitest Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Chain Drug Marketing Association; Target Corporation; Walgreens Company; WinCo Foods | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | McKesson | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose monohydrate; Magnesium stearate; Silicon dioxide; Cellulose, microcrystalline; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | A-S Medication Solutions; Carilion Materials Management; Qualitest Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 10 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Croscarmellose sodium; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Avera McKennan Hospital; Better Living Brands; Major Pharmaceuticals; Rite Aid | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Drug Formulation 11 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Cardinal Health; Great Lakes Wholesale Marketing & Sales; Harmon Stores | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Drug Formulation 12 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Magnesium stearate; Croscarmellose sodium; Microcrystalline cellulose
|
|||||
Dosage Form | Oral Tablet | |||||
Company | McKesson | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Drug Formulation 13 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Medtech Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 14 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Anhydrous lactose; Magnesium stearate; Croscarmellose sodium; Silicon dioxide; Cellulose, microcrystalline; Hypromelloses; Mineral oil
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Time Cap Labs | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 15 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Dibasic calcium phosphate dihydrate; Croscarmellose sodium; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Contract Pharmacal | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Drug Formulation 16 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Magnesium stearate; Croscarmellose sodium; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Acme United Corporation; Amerisource Bergen; CVS Pharmacy; Cardinal Health; Care One; Chain Drug Consortium; Chain Drug Marketing Association; Fred's; Good Sense; Harmon Stores; McKesson; Meijer; National Distribution Network; TopCare; Valu Merchandisers Company; Western Family Foods | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [5] | |||
Dimenhydrinate 25 mg tablet | Click to Show/Hide the Full List of Formulation(s): 2 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose; Fd&c yellow no. 6; Magnesium stearate; Mannitol; Sucrose; Povidone; Calcium phosphate, dibasic, anhydrous; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hydroxypropyl corn starch (5% substitution by weight)
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Sato Pharmaceutical | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [2] | |||
Mannitol | DIG Info | Glycine receptor alpha-1 (EC50 = 12589.25 nM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [8] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Aspartame; Magnesium stearate; Sorbitol; Citric acid monohydrate
|
|||||
Dosage Form | Chewable Tablet | |||||
Company | Medtech Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Aspartame | DIG Info | Pregnane X receptor (Ki = 13 uM) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.